Advent Pharma Ltd. reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was BDT 149.42 million compared to BDT 145.13 million a year ago. Net income was BDT 26.52 million compared to BDT 27.45 million a year ago. Basic earnings per share from continuing operations was BDT 0.28 compared to BDT 0.29 a year ago.
For the nine months, sales was BDT 432.4 million compared to BDT 410.64 million a year ago. Net income was BDT 90.81 million compared to BDT 89.88 million a year ago. Basic earnings per share from continuing operations was BDT 0.98 compared to BDT 0.97 a year ago.